Health officials have given a life-extending drug the green light for widespread NHS, giving hope to thousands of men facing a "death sentence" from prostate cancer.
The National Institute for Health and Care Excellence (Nice) said the drug enzalutamide, also known as xtandi, should be considered for use in the treatment of men with hormone relapsed prostate cancer that has spread to other parts of the body.
Nice said in its draft guidance that it was pleased to recommend the drug, which is manufactured by Astellas Pharma, for patients who have few other treatment options left.
More top news
Charlton Athletic Football Club have launched an internal investigation over an allegation of historical sexual abuse.
The government is "deeply concerned" by reports of UK weapons being used by the Saudis in strikes on civilians in Yemen, Boris Johnson says.
Cold and sunny for most, increasingly cloudy from the west. Cloud and wind spreading from the west of UK.